Thyrocare Technologies Ltd
NSE:THYROCARE

Watchlist Manager
Thyrocare Technologies Ltd Logo
Thyrocare Technologies Ltd
NSE:THYROCARE
Watchlist
Price: 452.6 INR -0.55% Market Closed
Market Cap: 72B INR
Section:
 

Relative Value

The Relative Value of one THYROCARE stock under the Base Case scenario is 436.9 INR. Compared to the current market price of 452.6 INR, Thyrocare Technologies Ltd is Overvalued by 3%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

THYROCARE Relative Value
Base Case
436.9 INR
Overvaluation 3%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.4
P/S
P/S
Price to Sales
9.4
vs History
20
vs Industry
22
Median 3Y
6
Median 5Y
6.7
Industry
2.4
Forward
8.5
More Details
56.4
P/E
P/E
Price to Earnings
56.4
vs History
20
vs Industry
11
Median 3Y
47.5
Median 5Y
43.6
Industry
22.9
Forward
41.8
More Details
31.4
P/OCF
P/OCF
Price to OCF
31.4
vs History
38
vs Industry
18
Median 3Y
23.3
Median 5Y
26.7
Industry
14.7
More Details
44.3
P/FCFE
P/FCFE
Price to FCFE
44.3
vs History
50
vs Industry
16
Median 3Y
36.7
Median 5Y
43.7
Industry
21.4
More Details
13.5
P/B
P/B
Price to Book Value
13.5
vs History
9
vs Industry
8
Median 3Y
6.9
Median 5Y
8.2
Industry
2.3
More Details
9.1
EV/S
EV/S
Enterprise Value to Sales
9.1
vs History
22
vs Industry
21
Median 3Y
5.9
Median 5Y
6.5
Industry
2.6
Forward
8.3
More Details
12.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.5
vs History
23
vs Industry
27
Median 3Y
8.3
Median 5Y
9.3
Industry
5.3
More Details
30.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
30.3
vs History
12
vs Industry
14
Median 3Y
23.9
Median 5Y
23.2
Industry
12.3
Forward
25.8
More Details
39.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
39.7
vs History
19
vs Industry
13
Median 3Y
34
Median 5Y
32.7
Industry
17.2
Forward
31.5
More Details
30.2
EV/OCF
EV/OCF
Enterprise Value to OCF
30.2
vs History
38
vs Industry
20
Median 3Y
23
Median 5Y
26
Industry
15
More Details
39.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
39.3
vs History
53
vs Industry
21
Median 3Y
33.5
Median 5Y
39.9
Industry
19
More Details
16.5
EV/IC
EV/IC
Enterprise Value to IC
16.5
vs History
4
vs Industry
9
Median 3Y
7.1
Median 5Y
8.9
Industry
1.9
More Details

Multiples Across Competitors

THYROCARE Competitors Multiples
Thyrocare Technologies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Thyrocare Technologies Ltd
NSE:THYROCARE
71.1B INR 9.4 56.4 30.3 39.7
US
CVS Health Corp
NYSE:CVS
102B USD 0.3 217.4 14.2 14.2
US
Cigna Corp
NYSE:CI
74.4B USD 0.3 12.1 7.8 9.9
US
Cigna Group
XMUN:CGN
64.7B EUR 0.3 12.3 7.8 10
DE
Fresenius SE & Co KGaA
XETRA:FRE
28.2B EUR 1.3 24.8 10.7 16.3
DE
Fresenius Medical Care AG
XMUN:FME
22.9B EUR 1.2 31.8 10.1 21.6
US
Laboratory Corporation of America Holdings
NYSE:LH
20.9B USD 1.5 24.4 13.3 18.6
US
Quest Diagnostics Inc
NYSE:DGX
19.4B USD 1.8 20.1 11.2 15.1
US
Guardant Health Inc
NASDAQ:GH
13.8B USD 15.3 -34.5 -36.4 -33
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.7B EUR 0.6 16.5 6.4 13.6
US
DaVita Inc
NYSE:DVA
7.9B USD 0.6 10.2 6.6 8.9

See Also

Summary
THYROCARE intrinsic value, competitors valuation, and company profile.
DCF Valuation
THYROCARE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
THYROCARE stock valuation using valuation multiples.
Wall Street Estimates
THYROCARE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
THYROCARE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 309,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.